High-level penicillin-nonsusceptible Streptococcus pneumoniae bacteremia: identification of a low-risk subgroup

Jörg J Ruhe1, Leann Myers, David Mushatt

  • 1Department of Medicine, Infectious Diseases Section, Tulane University School of Medicine, New Orleans, Louisiana 70112, USA.

Insights

A predictive model identified patients at low risk for high-level penicillin-resistant Streptococcus pneumoniae bacteremia. This allows for fluoroquinolone-sparing antibiotic regimens in low-risk individuals.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Clinical Pharmacy

Background:

  • High-level penicillin resistance in Streptococcus pneumoniae is linked to treatment failure.
  • Identifying patients at low risk for resistant bacteremia is crucial for effective treatment strategies.

Purpose of the Study:

  • To develop a predictive model for identifying patients at low risk of high-level penicillin-nonsusceptible S. pneumoniae bacteremia.
  • To guide empirical antibiotic treatment choices for pneumococcal bacteremia.

Main Methods:

  • A cross-sectional study of 303 patients with S. pneumoniae infections was conducted.
  • A predictive model was developed using baseline variables associated with high-level penicillin resistance.
  • Patient subgroups were categorized as low-risk or high-risk based on the model.

Main Results:

  • Penicillin resistance was observed in 32% of patients; high-level resistance in 11%.
  • Previous beta-lactam antibiotic use, stay in a risk area, and respiratory tract infection were key predictors.
  • No ceftriaxone resistance was found in the low-risk subgroup.

Conclusions:

  • A validated predictive model can identify patients at low risk for high-level penicillin-resistant pneumococcal bacteremia.
  • Low-risk patients may be suitable for empirical fluoroquinolone-sparing antibiotic regimens.
  • This approach can help optimize antibiotic use and mitigate resistance development.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...